July, 17 2025 Thursday 14:21 Hrs
  • SENSEX :   82,450.50

  • Top commodity trading and broking companies in India-183.98( -0.22%) 17-Jul-2025
top-arrow-market
Sensex 82458.08 -176.40  (-0.21) 17-Jul-2025
Previous Day Close
82634.48
Today's High/Low
High Low
  •  
  •  
82757.09 82397.97

Company News Details

Anuh Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
506260
INE489G01022
32.5297334
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ANUHPHR
21.72
1027.3
EPS(TTM)
Face Value()
Div & Yield %
4.72
5
0.73
 

Anuh Pharma Ltd
Anuh Pharma gains after inaugurating new manufacturing block in Maharashtra
Jul 15,2025
In a regulatory filing, the company stated that the new facility is expected to become operational within July 2025. Upon commencement, the plant will expand Anuh Pharma’s manufacturing capacity by an additional 200 metric tons per annum (MT/Annum).

Post-expansion, the company's total production capacity will increase from approximately 2,200 MT/Annum to 2,400 MT/Annum.

The newly inaugurated INT-1A block is also equipped with an additional 40 kiloliters (KL) of reactor capacity, enhancing the company’s infrastructure and positioning it to meet growing market demand more effectively.

Anuh Pharma, a bulk drug manufacturing company, is part of the Rs 8.5 bn SK Group of Companies, which employs 2000+ people across businesses such as manufacturing of APIs, pharma formulations, distribution, and logistics. Established in 1960, Anuh Pharma today is one of the largest manufacturers of macrolides and anti-TB products in India, besides being a major player in anti-bacterials, anti-malarials, and corticosteroids.

The company’s standalone net profit fell 18.9% to Rs 12.46 crore, while revenue from operations jumped 20.9% to Rs 198.14 crore in Q4 March 2025 over Q4 March 2024.

Top
Attention Investor:
Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers/Depository Participant.     KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, ,Mutual ).    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.